PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, 9033
N. diseases: 124; N. variants: 10
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Mental Disorders | Mental or Behavioral Dysfunction | 418 | 117 | 0.100 | None | 1.000 | 91 | 2015 | 2020 | |||||
|
disease | Mental Disorders | Mental or Behavioral Dysfunction | 63 | 6 | 0.100 | None | 0.933 | 30 | 2007 | 2020 | |||||
|
group | Neoplasms | Neoplastic Process | 10161 | 1644 | 0.100 | None | 1.000 | 15 | 1 | 2011 | 2019 | ||||
|
disease | Mental Disorders | Mental or Behavioral Dysfunction | 1719 | 297 | 0.100 | None | 0.900 | 10 | 2017 | 2020 | |||||
|
phenotype | Laboratory Procedure | 58 | 306 | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2013 | |||||
|
phenotype | Laboratory Procedure | 433 | 3282 | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||
|
disease | Neoplasms; Respiratory Tract Diseases | Neoplastic Process | 670 | 283 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||
|
disease | Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | Disease or Syndrome | 827 | 425 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||
|
group | Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | Disease or Syndrome | 1074 | 306 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||
|
phenotype | Clinical Attribute | 843 | 1931 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
group | Laboratory Procedure | 50 | 116 | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||
|
disease | Respiratory Tract Diseases | Disease or Syndrome | 1428 | 852 | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||
|
phenotype | Finding | 89 | 111 | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | |||||
|
phenotype | Clinical Attribute | 507 | 1037 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||
|
phenotype | Laboratory Procedure | 593 | 988 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Laboratory Procedure | 89 | 111 | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | |||||
|
phenotype | Laboratory Procedure | 563 | 1418 | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | |||||
|
phenotype | Laboratory Procedure | 223 | 371 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory or Test Result | 593 | 988 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
group | Cardiovascular Diseases | Disease or Syndrome | 1756 | 711 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||
|
phenotype | Behavior and Behavior Mechanisms | Mental or Behavioral Dysfunction | 1461 | 269 | 0.090 | None | 0.889 | 9 | 2017 | 2020 | |||||
|
disease | Behavior and Behavior Mechanisms | Mental or Behavioral Dysfunction | 1478 | 271 | 0.090 | None | 0.889 | 9 | 2017 | 2020 | |||||
|
disease | Mental or Behavioral Dysfunction | 10 | 0.040 | None | 1.000 | 4 | 2017 | 2019 | |||||||
|
group | Neoplasms | Neoplastic Process | 8221 | 1374 | 0.040 | None | 1.000 | 4 | 2017 | 2019 | |||||
|
group | Neoplasms | Neoplastic Process | 8621 | 1641 | 0.040 | None | 1.000 | 4 | 2017 | 2019 |